Delivery Order 75N92019D00016-75N92022F00001
Award Date
3/1/22
Potential Completion Date
7/5/24
Potential Value
$1.7M
Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $213,371, was issued by the National Heart Lung and Blood Institute (NHLBI) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The award is for the Gene Therapy Resource Program (GTRP), Task Area A, which involves core administrative tasks. The contract is a Delivery Order with a Cost No Fee pricing type, with a period of performance ending on June 30, 2024. The award does not...
The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, has been awarded a delivery order against the Gene Therapy Resource Program (GTRP) by the National Heart, Lung and Blood Institute of the National Institutes of Health. Valued at $1,454,186.49, this cost-no-fee contract calls for the prime contractor to perform preclinical vector core laboratory scientific activities under Task Area B of the GTRP. Place of performance will be...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Delivery Order to The Trustees of the University of Pennsylvania (Penn) on August 23, 2019 with a potential value of $1,408,152.00 for "TASK AREA B: PRE-CLINICAL VECTOR CORE LABORATORY SCIENTIFIC ACTIVITIES" under the Gene Therapy Resource Program (GTRP). This is a Cost No Fee contract with a completion date of September 22, 2021. Penn is a private university...
This is a firm-fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The $14,917.20 contract is for gene therapy vector services to support NICHD's research objectives. The contract does not have a set-aside designation, reflecting the university's status as a large research institution....
The U.S. National Heart Lung and Blood Institute (NHLBI) awarded a $598,672.91 cost-plus-fixed-fee task order contract to The Children's Hospital of Philadelphia (CHOP) for the Gene Therapy Resource Program (GTRP) AAV Vector Production Core Lab. This task order, which is part of a larger GTRP program, has a period of performance through May 31, 2017 and a current funding level of $325,007. The contract does not have a set-aside designation. CHOP, a leading pediatric hospital and research...
This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) for the "Gene Therapy Resource Program (GTRP), Pharmacology-Toxicology Core Lab." The contract is a $1,748,740.00 cost-plus-fixed-fee delivery order with a period of performance through July 31, 2017. LBERI, a non-profit organization doing business as...
This is a definitive cost-no-fee contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian federal agency, to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The $12,427,447.18 contract is for a randomized clinical trial of genotype-guided dosing of warfarin therapy. The contract does not have a set-aside designation, reflecting the University of Pennsylvania's status as a large research...
The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health, has awarded a $21,072.00 firm-fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract is for the production of MAXI DNA constructs containing the EF1a promoter, human SirT3-3xFLAG, and WPRE and BGH elements. The contract has an ultimate completion date of August 31,...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $15,143 firm fixed price purchase order to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract is to be performed in Philadelphia, Pennsylvania over a one day period from July 24, 2023 through July 24, 2023. No additional details were provided on products or services requested under the...
This is a $227,383.75 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The award has no set-aside designation and is for a "Global Perspective Course". The award is part of a larger indefinite delivery contract with the National Institute of Allergy and Infectious Diseases (NIAID) that allows Penn to provide a range of preclinical...